Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Cert. of designation
Quarterly results
Appointed COO
Appointed director
Perspective Therapeutics, Inc. (ISR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
08/11/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
05/15/2023 8-K Appointed a new director
Docs: "Press Release"
03/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation"
03/13/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Separation Agreement between Perspective Therapeutics, Inc., Isoray Medical, Inc., and William Cavanagh III, effective March 10, 2023"
03/13/2023 8-K Other Events  Interactive Data
02/10/2023 8-K Quarterly results
02/06/2023 8-K Appointed a new director
Docs: "Form of Registration Rights and Lock-Up Agreement",
"Separation Agreement between Isoray Inc. and Lori A. Woods",
"Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine"
01/30/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders"
01/12/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023 RICHLAND, WASHINGTON – January 12, 2023 – Isoray, Inc. , a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that the January 12th, 2023, adjourned Annual Meeting of Stockholders is being adjourned until January 27th, 2023, to provide stockholders who have not yet voted with additional time to vote on Proposal 1, approval of an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock. This vote, which requires approval by a majority of the outstanding shares, is required to proceed with the proposed merger with Viewpoint Molecular Targeting, Inc. The Board of..."
12/14/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
09/28/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Financ...
Docs: "Agreement and Plan of Merger"
09/28/2022 8-K Quarterly results
Docs: "Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results RICHLAND, WASHINGTON – September 28, 2022 – Isoray, Inc. , a medical technology company and innovator in seed brachytherapy, today announced that it has entered into a definitive agreement to acquire Viewpoint Molecular Targeting, Inc. a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents. Under the terms of the agreement, a newly formed wholly owned subsidiary of Isoray will merge with and into Viewpoint, with Viewpoint becoming a wholly owned subsidiary of Isoray. At the effective time of the merger, each issued and outstanding share of common stock of Viewpoint will be converted into the right to receive 3.3212 shares of ...",
"Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022"
05/10/2022 8-K Quarterly results
04/15/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Addendum No. 3 to Supply Contract, by and between Isoray Medical, Inc. and Joint Stock Company",
"Addendum No. 4 to Supply Contract, by and between Isoray Medical, Inc. and Joint Stock Company"
02/08/2022 8-K Quarterly results
12/17/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Service Agreement, between Isoray Medical, Inc. and MedikorPharma-Ural LLC"
12/09/2021 8-K Quarterly results
11/23/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amendment No. 3 to Amended and Restated Manufacturing and Supply Agreement between Isoray Medical, Inc. and GT Medical Technologies, Inc. (confidential portions of the exhibit have been omitted)"
11/10/2021 8-K Quarterly results
Docs: "September 30, June 30, 2021 2021 ASSETS Current assets: Cash and cash equivalents $ 61,690 $ 63,828 Accounts receivable, net 1,902 2,013 Inventory 1,060 980 Prepaid expenses and other current assets 306 481 Total current assets 64,958 67,302 Property and equipment, net 1,953 1,958 Right of use asset, net 705 768 Restricted cash 182 182 Inventory, non-current 792 76 Other assets, net 120 130 Total assets $ 68,710 $ 70,416 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 768 $ 730 Lease liability 256 252 Accrued protocol expense 120 98 Accrued radioactive waste disposal 102 100 Accrued payroll and related taxes 300 362 Accrued vacation 253 259 Total current liabilities 1,799 1,801 Non-current liabilities: Lease liability, non-current 459 524 A...",
"Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021"
09/21/2021 8-K Quarterly results
Docs: "Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results",
"Investor Relations: Mark Levin"
09/15/2021 8-K Quarterly results
08/25/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Addendum No. 2 to Supply Contract, by and between Isoray Medical, Inc. and Joint Stock Company"
08/03/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Addendum No. 1 to Supply Contract, by and between Isoray Medical, Inc. and Joint Stock Company"
06/03/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/05/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy